There really is no routine day in the medical device industry.

It was a busy news week in medtech. Here's what you need to know to bring you up to speed quickly.

The Irvine, CA-based company first won approval for its TAVR device 10 years ago. Now more companies are entering into the market.

Dr. Antonia Chen shares her insights as a practicing orthopedic surgeon on why antibacterial sutures should be standard in every U.S. operating room.

The agency tends to agree with advisory committee recommendations, but not always.

Despite getting shot down by a recent FDA advisory panel, Integra's management team still seems confident that the agency will ultimately approve SurgiMend for post-mastectomy breast reconstruction.

Will this fee decision benefit the San Francisco, CA-based company in the long run?

The Waltham, MA-based was able to beat consensus. Will its success herald even more M&A

A Delaware jury has ordered Nevro to pay Boston Scientific $20 million regarding the infringement of two patents for spinal cord stimulation technology.